Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Amortization of Deferred Charges (2021 - 2025)

Historic Amortization of Deferred Charges for Kezar Life Sciences (KZR) over the last 5 years, with Q3 2025 value amounting to $37000.0.

  • Kezar Life Sciences' Amortization of Deferred Charges fell 4218.75% to $37000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $304000.0, marking a year-over-year increase of 2063.49%. This contributed to the annual value of $259000.0 for FY2024, which is 1021.28% up from last year.
  • Latest data reveals that Kezar Life Sciences reported Amortization of Deferred Charges of $37000.0 as of Q3 2025, which was down 4218.75% from $42000.0 recorded in Q2 2025.
  • Kezar Life Sciences' 5-year Amortization of Deferred Charges high stood at $159000.0 for Q1 2025, and its period low was $37000.0 during Q3 2025.
  • For the 5-year period, Kezar Life Sciences' Amortization of Deferred Charges averaged around $64687.5, with its median value being $59000.0 (2023).
  • Examining YoY changes over the last 5 years, Kezar Life Sciences' Amortization of Deferred Charges showed a top increase of 14843.75% in 2025 and a maximum decrease of 4218.75% in 2025.
  • Quarter analysis of 5 years shows Kezar Life Sciences' Amortization of Deferred Charges stood at $91000.0 in 2021, then plummeted by 40.66% to $54000.0 in 2022, then increased by 9.26% to $59000.0 in 2023, then increased by 11.86% to $66000.0 in 2024, then plummeted by 43.94% to $37000.0 in 2025.
  • Its last three reported values are $37000.0 in Q3 2025, $42000.0 for Q2 2025, and $159000.0 during Q1 2025.